Events - Spark Newswire

3 minute read

Why Cannabis Is Recession-Resistant & Turning Challenges Into Opportunities, Industry Expert Explains

Today, 9:57 AM

It is safe to say that the cannabis industry would not have progressed as much as it has if it were not for the people who believed in it. Cannabis advocates, lobbyists, growers, operators, consumers and researchers have consistently played a crucial role in the space. Nevertheless, without capital, the industry wouldn’t have advanced to where it is today.

AAWH

2 minute read

Acquisitions & Expansion Boost Marimed’s Q4 Revenue 6% Sequentially, 2022 Sales Increased To $134M

By Maureen Meehan

Today, 9:57 AM

MariMed, Inc. (OTCQX: MRMD) announced its financial results Wednesday afternoon for the fourth quarter and full year ended December 31, 2022. The company reported sales for the year increased to $134 million, compared with $121.5 million the prior year.

MRMD

2 minute read

Cathie Wood Says Half-Price Robotaxis Will Steal The Show At Tesla’s Investor Day: Why The Event Could Prove That Competitors Are Doomed

By Adam Eckert

Today, 9:57 AM

Ark Invest founder and CEO Cathie Wood rose to fame because of her early call on Tesla Inc (NASDAQ: TSLA).

TSLA

2 minute read

Goldman’s CEO Admits There’s ‘More Work To Do’ Amid Struggles, Eyes New Strategy To Supercharge Growth

By Adam Eckert

Today, 9:57 AM

Goldman Sachs Group Inc (NYSE: GS) is shifting its focus to asset and wealth management as it expects those areas to be the main drivers of growth in the coming years.

2 minute read

Elon Musk’s Embrace Of Cannabis On Twitter: Weed Companies Still Celebrating Win-Win Situation

By Maureen Meehan

Today, 9:57 AM

When Elon Musk, CEO of Tesla (NASDAQ: TSLA) and Twitter CEO decided to allow cannabis brands onto Twitter

TCNNF

1 minute read

Events
News

Celldex Therapeutics Presented Data from Barzolvolimab Phase 1b Study in Chronic Spontaneous Urticaria at AAAAI 2023; Said Rapid, Profound And Durable Responses Across Multiple Dosing Groups With Favorable Safety Profile Observed

By Charles Gross

Today, 9:57 AM

Celldex Therapeutics, Inc. (NASDAQ: CLDX) announced today updated data from the Company's Phase 1b clinical trial of barzolvolimab in patients with moderate to severe chronic spontaneous urticaria (CSU) refractory to antihistamines.

CLDX

1 minute read

Nokia Announced New Brand Identity; Plans To Review Business Units For Alternatives, Including Possible Divestment; CEO Lundmark Said Seeks to Increase Enterprise Business From 8% of Sales To Double-Digits

By Charles Gross

Today, 9:57 AM

-Reuters https://www.reuters.com/technology/nokia-changes-iconic-logo-signal-strategy-shift-2023-02-26/

NOK

5 minute read

‘New Phase 3 Data Presented At WORLDSymposium Reinforce Nexviazyme As Potential New Standard Of Care For All People Living With Late-Onset Pompe Disease’

By Happy Mohamed

Today, 9:57 AM

New Phase 3 data presented at WORLDSymposium™ reinforce Nexviazyme® (avalglucosidase alfa) as potential new standard of care for all people living with

SNY

5 minute read

Additional Interim Data From Phase I/II Trial Of REGENXBIO’S RGX-111 For The Treatment Of Severe MPS I Presented At WORLDSymposium

By Happy Mohamed

Today, 9:57 AM

RGX-111 is an investigational AAV Therapeutic for the treatment of severe MPS I that is part of REGENXBIO's clinical-stage pipeline of neurodegenerative disease programs RGX-111, a potential one-time gene

RGNX

2 minute read

Elon Musk Says Tesla Inheriting ‘Incredible’ Silicon Valley Legacy With California Engineering HQ

By Shivdeep Dhaliwal

Today, 9:57 AM

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk said on Wednesday that the automaker was moving the company’s global engineering headquarters to Palo Alto, California. An

TSLA